Trialect

Verified

Highlighted Topic: Advanced Biomaterials for Biomedical Research

National Institutes of Health

Biomedical research with engineered systems faces a fundamental challenge: traditional biomaterials fail to recapitulate the tissue complexity, heterogeneity, and dynamic evolution seen in vivo . Conventional scaffolds and hydrogels suffer from batch variability, rapid uncontrolled gelation, and growth factor content which confound mechanistic studies. Tissue-sourced extracellular matrices lack reproducibility essential for rigorous, controlled experimentation.

Recent advances in bioprinting, lithography, electrospinning, and synthetic biology enable design of materials better mimicking physiological conditions. However, gaps remain in modeling dynamic physical properties—stiffness gradients, viscoelasticity, stress relaxation, temporal evolution—characteristic of tissue microenvironments. Materials detecting or responding to tissue-specific changes (pH fluctuations, hypoxia, oxygen gradients, metabolite concentrations, cytokine profiles) would enable researchers to interrogate or model complex biological systems (e.g. early lesions and how tumors modify niches allowing invasion and metastasis).

For example, recent collaborative approaches between material scientists and cancer researchers have enabled understanding of the physical properties of cancer evolution. Materials scientists bring expertise designing responsive, tunable systems with controlled properties. Cancer biologists provide understanding of tumor biology, microenvironmental cues, and critical research questions. Together, these collaborations spur the development of biomaterial systems capable of responding dynamically to tumor-relevant stimuli, enabling new insights into cancer initiation, progression, metastasis, and therapeutic resistance that are challenging to study with current approaches.

This topic encourages the adaptation, integration and development of innovative, advanced biomaterials that enable material scientists and biomedical researchers to collaboratively address fundamental challenges in understanding biology.

Apply through an appropriate NIH Parent Funding Announcement or another broad NIH opportunity available on Grants.gov .

Expiration Date: September 9, 2028

Specialties

Engineering and Physical Sciences

Interdisciplinary

Medical - Basic Science

Environmental & Life Sciences

Medical

Medical - Translational

Eligibility Requirements

Sponsor Details

Sponsor Institute/Organizations: National Institutes of Health

Sponsor Type: Government/Federal

Address: National Institutes of Health; 31 Center Drive; MSC 2220; Bethesda; MD 20892-2220; USA

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity